2024-11-19 05:38:33
Alphamab Oncology Presents the updated data from Phase 2 Clinical trial on KN046 Combined with platinum doublet chemotherapy as first-line(1L)treatment for NSCLC at ESMO 2022
Corporate/ 2023-07-24
Alphamab Oncology Presents the updated d...

2-year survival data of this study were presented: KN046 combined with platinum doublet chemotherapy showed promising efficacy and well tole...

MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS
Corporate/ 2023-07-24
MD ANDERSON AND RADIOPHARM THERANOSTICS ...

MELBOURNE,Australia,Sept. 14,2022-- The University of Texas MD Anderson Cancer Center (\'MD Anderson\') and Radiopharm Theranostics Limited ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release